NZ613614A - Sphingoglycolipid compounds and uses - Google Patents

Sphingoglycolipid compounds and uses Download PDF

Info

Publication number
NZ613614A
NZ613614A NZ61361412A NZ61361412A NZ613614A NZ 613614 A NZ613614 A NZ 613614A NZ 61361412 A NZ61361412 A NZ 61361412A NZ 61361412 A NZ61361412 A NZ 61361412A NZ 613614 A NZ613614 A NZ 613614A
Authority
NZ
New Zealand
Prior art keywords
compounds
sphingoglycolipid
compositions
conditions
diseases
Prior art date
Application number
NZ61361412A
Inventor
Regan James Anderson
Benjamin Jason Compton
Colin Malcolm Hayman
Ian Francis Hermans
David Samuel Larsen
Gavin Frank Painter
Original Assignee
Regan James Anderson
Benjamin Jason Compton
Colin Malcolm Hayman
Ian Francis Hermans
David Samuel Larsen
Gavin Frank Painter
Callaghan Innovation Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regan James Anderson, Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, David Samuel Larsen, Gavin Frank Painter, Callaghan Innovation Res Ltd filed Critical Regan James Anderson
Priority to NZ61361412A priority Critical patent/NZ613614A/en
Publication of NZ613614A publication Critical patent/NZ613614A/en

Links

Abstract

The disclosure relates to certain sphingoglycolipid analogues, particularly alpha-galactosylceramide derivatives represented by formula (I), and precursors of these compounds, wherein the variables are as defined in the specification. Compositions comprising these compounds, including pharmaceutical compositions and adjuvant compositions, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using such compounds, especially diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer are also disclosed.
NZ61361412A 2012-07-26 2012-07-26 Sphingoglycolipid compounds and uses NZ613614A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ61361412A NZ613614A (en) 2012-07-26 2012-07-26 Sphingoglycolipid compounds and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ61361412A NZ613614A (en) 2012-07-26 2012-07-26 Sphingoglycolipid compounds and uses

Publications (1)

Publication Number Publication Date
NZ613614A true NZ613614A (en) 2015-01-30

Family

ID=52464896

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ61361412A NZ613614A (en) 2012-07-26 2012-07-26 Sphingoglycolipid compounds and uses

Country Status (1)

Country Link
NZ (1) NZ613614A (en)

Similar Documents

Publication Publication Date Title
NZ629996A (en) 2’- substituted carba-nucleoside analogs for antiviral treatment
WO2017059385A8 (en) 11,13-modified saxitoxins for the treatment of pain
PH12015501385A1 (en) Autotaxin inhibitors
MX343706B (en) Novel heterocyclic derivatives.
IN2012DN02139A (en)
NZ608116A (en) Triazine-oxadiazoles
WO2013163190A8 (en) Dna-pk inhibitors
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
IN2015KN00492A (en)
NZ707859A (en) Inhibitors of sodium glucose cotransporter 1
MX2013010898A (en) Novel pyrimidine derivatives.
EA201491028A1 (en) METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES
TN2014000112A1 (en) Ep1 receptor ligands
MX2016007128A (en) Ccr6 compounds.
MD4780C1 (en) P-substituted asymmetric ureas and medical uses thereof
IN2014DN03010A (en)
PH12015502703A1 (en) Pharmaceutical compositions
NZ613614A (en) Sphingoglycolipid compounds and uses
WO2009151495A3 (en) Oxazole compounds, compositions and methods of use
WO2014102820A3 (en) Rivaroxaban intermediate and preparation thereof
TN2013000441A1 (en) 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
TN2013000089A1 (en) Triazine-oxadiazoles
TN2013000327A1 (en) Novel heterocyclic derivatives
TN2011000035A1 (en) Organic compounds

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2018 BY CATALYST INTELLECTUAL PROPERTY

Effective date: 20170623

ASS Change of ownership

Owner name: VICTORIA LINK LIMITED, NZ

Effective date: 20180619

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2019 BY DR. STEFFEN SCHWARZ IPRIS AG

Effective date: 20180716

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2020 BY DR. STEFFEN SCHWARZ IPRIS AG

Effective date: 20190705

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2021 BY BIRGIT KNAACK

Effective date: 20200714

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2022 BY CPA GLOBAL

Effective date: 20210610

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2023 BY CPA GLOBAL

Effective date: 20220609